Meet the advisor panel

Dr. Valerieva is associate professor of allergology at the Medical University of Sofia, Bulgaria. She is specialized in allergology and her PhD is in allergology and immunopathology. Dr. Valerieva is a member and part of the Executive Board of the Bulgarian Society of Allergology, and serves as a National Allergy Society representative at the EAACI NAS Committee. She has interest in hereditary angioedema and other rare forms of angioedema. She was trained as a research fellow with Prof. Marco Cicardi at the Luigi Sacco Hospital in Milan, Italy.

In 2018, Dr. Valerieva received a certificate of excellence from the European Academy of Allergy and Clinical Immunology for completing the Knowledge Examination in Allergology and Clinical Immunology. In 2019, she was awarded an “Acad. Assen Hadziolov” prize of the Medical University of Sofia for young researchers and contribution to medical science and teaching. Dr. Anna Valerieva is a department deputy of the ACARE Centre in University Hospital Alexandrovska in Sofia, Bulgaria.

Dr. Burnette completed her allergy fellowship training at the University of Virginia. She is a clinical physician specialist who evaluates and manages adult and pediatric patients with allergic disease and immunologic disorders. She's board certified in both allergy/immunology and pediatrics. Her clinical interests include hereditary angioedema, urticaria, asthma, and atopic dermatitis.

Dr. Burnette has a special expertise in biologic utilization for chronic moderate to severe disease in the allergy and immunology space.

A sought-after speaker and consultant, she has given numerous oral presentations and contributed to an array of advisory boards on these areas of interest in her community and throughout the country. Dr. Burnette has served as a primary author and co-author for several peer-reviewed journal manuscripts and oral abstracts, and also co-presented virtual CME podcasts/webinars and live national broadcasts during her career.

Dr. Jones received his medical degree from Penn State College of Medicine. He performed a residency in internal medicine at Creighton University Medical Center in Omaha, Nebraska, where he went on to complete a fellowship in allergy, asthma, and immunology. Dr. Jones is board certified in allergy and immunology.

In 2008, Dr. Jones founded Rocky Mountain Allergy, an internationally recognized treatment center known for its innovative food allergy treatment program that offers oral immunotherapy. Since then, Dr. Jones has helped found several companies. He is co-founder and president of the nonprofit Food Allergy Support Team, co-founder of The Immunity Group Australia, and is co-founder and co-manager of Global Food Initiative. Dr. Jones is also the director of Allergy Microbiome Foundation, a non-profit organization dedicated to advancing the science of integrated prevention and treatment of allergic disorders.

Dr. Jones has been principal investigator for several safety and efficacy trials on therapies for persistent asthma, primary immunodeficiency, and angioedema. He presents nationally and internationally on allergy and immunology topics and has authored articles in publications such as Journal of Food Allergy, World Allergy Organization Journal, and Annals of Allergy, Asthma & Immunology. Dr. Jones is a fellow of the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology. He is a member of the AAAAI Food Allergy Adverse Reactions Committee and the Immunology Practice Management Committee. Dr. Jones has been recognized multiple times in Who’s Who Top Doctors Honors Edition. He won the APEX Award for Publication Excellence, 2023. He also won #1 Top Allergist in “Salt Lake City Weekly”, Best of Utah Body and Mind edition 2022. He has been voted as one of America’s Most Honored Doctors multiple times, Most Compassionate Doctor multiple times, and is an HAE Allies Award Winner along with Patient’s Choice Award.

Emily Carne has worked as the lead nurse in the service since 2001. Emily has a particular interest in and has published on different aspects of primary immunodeficiency, including quality of life, home therapy, and burden of treatment.

She has held positions in the committees of the BSI-CIAS, UKPIN, INGID, and BSACI; was chair of IANG; and sits on the Medical Advisory Panel for IDUK and IDPGW.

She was the first recipient of the INGID award for worldwide services to immunology in 2017, won the Royal College of Nursing Wales Clinical Nurse Specialist of the Year in 2016, and Cardiff and Vale Chairs award for clinical excellence in 2015. She was named the South Wales Echo Health Hero in May 2018, and her nursing team won a global patient safety day award in 2022 for work undertaken during the COVID pandemic.

Dr. Stephen Betschel is a clinician-teacher and associate professor in the Department of Medicine’s Division of Clinical Immunology and Allergy, and a staff clinical immunologist and allergist in the Division of Allergy and Clinical Immunology at St. Michael’s Hospital and Division of Respirology at University Health Network. Dr. Betschel also holds courtesy appointments at Michael Garron Hospital and St. Joseph’s Health Centre. He is the departmental division director of Clinical Immunology and Allergy in the Department of Medicine at the University of Toronto.

Dr. Betschel earned a medical degree at McMaster University in Hamilton, Ontario, Canada. He completed the Master Teacher Program in the Department of Internal Medicine at the University of Toronto. His extensive service to the medical community is demonstrated through various leadership positions locally, nationally, and internationally. Dr. Betschel served for 14 years as the training program director in Clinical Immunology and Allergy at the University of Toronto, and he currently serves as the chair of the Canadian Hereditary Angioedema Network, and has been a member of the National Specialty Committee for over a decade.

Dr. Betschel’s focus is on rare diseases. He is the lead author on the Canadian and International Guidelines for Hereditary Angioedema and serves on the steering committee for the World Allergy Organization HAE guidelines. He is director of the Adult Primary Immunodeficiency Clinic at St. Michael’s Hospital.

Dr. Betschel has served as principal investigator for clinical studies in HAE as well as in other topics in allergy and immunology. He has authored or co-authored several book chapters and over 60 peer-reviewed journal articles and publications.